<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 325 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page324.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=325">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 325 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 325</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=325"><img src="../thumb/325.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>288 / 2020-04                                                      Endocrine System - 19.1.1 / 19.1.2
   Contraindications: Safety & effic.not est.in childr.&lt;18 yrs   Dosage: Indiv.accord.to bld.gluc.lev.at low.dos.to achiev.desir.me-  Metformin: Init.at 15 or 30 mg once dly.in combin. with current
   Side effects: Hypoglycaem., anti-insul.antibod. product., poss.vis.  tabol.contr. Sngl.dly.dos.norm. suffic. to provide metabol.contr.over   metformin dos.
   impairm. with mark.change in glycaem.contr., lipohypertrophy/-dys-  24 hrs. Take bef.a substant.breakf./1st main.meal of the day. Do not   Insulin: Init.at 15 or 30 mg once dly.in combin. with current insulin
   trophy, loc.reacts., allerg. reacts., sod.retent.& oed.  skip meals aft.tab.is taken. Swallow whole. Init: 1 mg once dly.which   dos. In case of hypoglycaem./ plasma gluc.conc.decr.to less than
   Warnings and special precautions: Pts./relat. to be alert to poss.  may be grad.incr.at interv. of 1-2 wks.by 1 mg-2 mg-3 mg-4 mg-6 mg   5,5 mmol/L, decr. either the insulin/pioglitazone dos. Furth.adjustm.
   hypoglycaem., where sequelae of hypoglycaem.episod.poss.of clinic.  increm. Max.dos.8 mg/day not to be exceed. Usual. dly.dos: 1-4 mg.   should be indiv.based on gluc.-low.respons.
   signific., circumstanc.where warn.sympts.of hypoglycaem. diminish/   Improv.diab.contr.is assoc. with improv.insul.sensitiv.allow.for reduc.   Contraindications: Hepat.impairm/act.liv.dis., serum transami-
   absent, elderly, monit. gluc.& adjust dos.on indiv.basis, consid.poss.   requirem. theref.dos.reduct.must be consid.in time. Proced. same as   nase levels &gt;2,5x upper norm. limit., CF, pregn., lactat., type 1 diab.
   recurr./unrecogn.esp.nocturn.hypoglycaem.if norm./decr.glycat.hae-  for init.dos., start.with dly.dos.of 1 mg when substit.ther.for other oral   mellit., diabet.ketoacidos., curr.bladd.Ca/hist.thereof, uninvest.
   moglob.values noted, ren./ hepat.impairm., pres.of insul.antibod.  antidiab./ switch.from max. dos.of anoth. oral antidiab.  macroscop.haematur., safety & effic.in childr. not est., New York
   may req. dos.adjustm., poss.tempor.worsen.of diabet. retinopathy   Contraindications: Sulphonylurea or other sulphonamide hypers-  Heart Assoc.class III & IV.
   with intensificat.of insul.ther.with abrupt improv.glycaem.control,   ens., safety in pregn.& lactat.not est., imp.liv.funct., mod.to sev.imp.  Side effects: URTI, pharyngit., sinusit., incr. appet., myalg., bone
   rotate inj.sites, maint.carbohydr.supplies dur. intercurr.illn., take pre-  ren. funct., childr., type 1 diab.mellit.  fract., arthralg., musc.cramp, haematur., alopec., vis.disturbs., hypo-
   caut.to avoid.hypoglycaem.if driv., safety in pregn.& lactat.not est.,   Side effects: Hypoglycaem.somet.life-threat., vis. impairm. esp.at   aesthes., headache, dizzin., paraesthes., anaem., hypoglycaem. poss.
   never use for treatm.of diabet.ketoacidos., see lit.regard.change over   start of treatm., GI disturbs., metall. taste, weight gain, imp.liv.funct.,   freq.dur.combin.ther.with sulphonylur./ insul., insomn., anaphylact./
   from other insulin(s), do not mix.with other insul., do not dil., metabol.  hepatit. poss. lead.to liv.fail., bld.dyscras., CNS effs., dizzin., allerg./  skin reacts., angioed., CCF, oed., palpitat., weight gain, bladd. Ca,
   monit. recomm.dur. changeover & init.wks.thereaft., not for IV admin.   pseudo-allerg.reacts.poss.life-threat. somet.progress.to shock, dr.to   tooth disord., back pain.
   which could result in sev.hypoglycaem., not intend. for insul.infus.  be alert.if ser. hypersens.sympt.occur, skin reacts.incl. erythema mul-  Special precautions: Liv.funct.monit.essent.bef. init. ther.then
   pump admin., as a clear sol. it does not require re-suspens.bef.use.  tiforme/ Stev.John.syndr./exfol. dermatit., photosens.  2 mnthly for 1 yr.& theraft.period., discont. treatm. if ALT incr.to 2,5x
   Drug interactions: Oral antidiabet.agents/ACE-inhibit./disop-  Special precautions: Incr.CV mortalit.risk, bld. gluc. contr.chang. in   baseline/jaund. observ., poss.resumpt.of ovulat.in pre-menopaus.
   yramide/fibrates/fluoxetine/ MAOI incl.linezolid/, pentoxifylline/  case of admin./discont. admin. cert.concom.meds., gluc.lev.in bld.&   anovulat. insul. resist.pts.& theref.adeq. contracept. advis., concom.
   salicylates & sulfonamide antibiot.may enhanc.bld.gluc.low.eff.,   urine/ glycat.Hb proport. to be monit.reg., weight & lifest. chang./  gemfibrozil/simil. CYP 2C8 inhibits./ rifampicin, ren.insuffic., review
   corticoster./ danazol/diazoxide/diuret./glucagon/ isoniazid/ oes-  other fact.caus.incr.suscept.to hypo-/hyperglycaem., hypoglycaem.  3-6 mnthly to assess adeq.of treatm.respons., cons. benef./ risk in
   trog./progestog./phenothiaz.deriv./ somatropin/ sympathomimet./  sympts.mediat.by counter-regulat.hormon.respons., fact.predispos.   elderly, bladd.Ca risk fact., pt.to alert dr.if unexpl. macroscop.hae-
   thyroid hormon./ protease inibit.& atypic.antipyschot.may reduc.  to hypoglycaem., pt.instruct.on signs of hypoglycaem., poss.deterio-  matur./dysur./ urin. urgency devel.dur.treatm., requirem.poss. change
   bld. gluc.low.eff., ß-block./clonid/Li & alcohol either potent.or weak.  rat.of bld.gluc.contr. und. stressors, insul.treatm.of choice in NIDDM   dur.per.of stress, eff.only exerc.in pres.of insul., Hb & haematocrit
   bld.gluc.low. eff., pentamid.may cause hypoglycaem.follow.by hy-  with ren.& hepat.dysfunct.  decr., oed., init.dos.at low. approv. dos. in pts.with NYHA class II
   perglycaem., signs of adrenerg.counter-regulat.reduc./absent und.   Drug interactions: Hypoglycaem.poss.with insul. & other oral   syst. HF & incr. dos.grad.only aft.sev.mnths.ther.with careful monit.,
   influence of sympatholyt.    antidiab./ MAOI & ACE inhibit./ miconazole/ anabol. ster. & male   elderly as incr.risk of ser.HF., lact. intol.
                                sex horm./para-aminonsalicycl.acid/chloramphenicol/high dos.   Drug Interactions: Incr.hypoglycaem.risk with concom.oral hy-
   TRESIBA, Novo Nordisk        parent.pentoxifyll./coumarin deriv./ phenylbutazone/ azapropa-  poglycaem.agents/ insulin, poss. reduc.effic.of OC’s, ketoconazole
   Insulin degludec             zone/oxyphenbutazone/ cyclophospham./ probenecid/disopyra-  decr.metabol., AUC incr.with gemfibrozil, AUC halv. with concom.
   Indications: Diab.mellit.treatm in adults and childr. &gt; 1yr.as basal   mide/ quinolon./ fenfluramine/salicylat./ sulphinpyrazone/ fibrat./  rifampicin, midazolam ser.conc.reduc.
   add on co-med.in inadeq.control.pts.  sulfonam.antibiot./ fluoxet./ tetracycl., poss.hyperglycaem.with
   (S3) SOL.FOR INJ., 47/21.1/0108, 0109  acetazolamide/ protract.laxativ./barbitur./high dos. nicotin. acid/   ADCO-GLUCOMED, AI Pharm Ltd [P/S]
   720490-001: 100 U/ml, 5x3 ml, penfill, R980,17  corticoster./oestrog.& progestog./ diazoxide/ phenothiazin./diurets.,   Gliclazide.
   723864-001: 100 U/ml, 5x3 ml, Flextouch, R980,17  phenytoin/ adrenal. & other sympathomimet./glucagon/ rifampicin/   Indications: Non insul.depend.diabet.mellit. type II where diet.
   Dosage: Admin.SC 1xdly. Indiv.dos. 1 Tresiba unit = 1 IU human   thyroid hormon., potent./weaken.bld. gluc. lower. eff.with H 2 recept.  managem.alone insuffic.
   insul.& 1 unit of all other insul. analog. Ensure min. 8 hrs.betw.inj.  antagon./ß-block./ clonidine/ reserpine/ac.& chron.alcoh.intake,   (S3) TABS. 32/21.2/0089.
   In pts. with type 2 diabet.mellit.Tresiba can be admin. alone/in   coumarin derivats. eff.may be potent./weaken., sympatholytic meds.  834599-007: 80 mg, 60, R64,91
   any combinat.with oral antidiabet. meds./ GLP-1 recept.agon.&   blunt adrenerg.respons.to hypoglycaem.  834599-015: 80 mg, 500, R540,92
   bolus insul.                                               Dosage: Tot.dly.dos.may vary from 80-320 mg given in div.dos.
   In type 1 diabet.mellit.Tresiba must be combin. with short-/rapid-act.   ACCORD METFORMIN, Accord [P/S]  pref.with meals.
   insul.to cover mealtime insul. requirem.  Metformin HCl.   Gen.dos: 2 tabs./day giv.as 1 tab.in the morn.& 1 tab.in the even.
   Insul.dos.adjustm.poss.necess.if pts.undertak.incr. physic. activ./  Indications: Type II diab.mellit.when diet.fail & esp.if pt.is over-  Contraindications: Ketoacidosis., sev.ren./ hepat./adren./thyroid
   change diet/dur.concomit.illn.  weight, alone as init.ther./ combinat. ther.with sulphonylurea &/  dysfunct., hyperthyroid., sulphonam.intol., unstab.diab., pregn.,
   Type 2 diab.mellit: Init.recomm.dly start.dos 10 U once dly fol-  or insul.  lactat., juvenile onset diab., infect., stress/trauma, undergo.surg.
   low.by indiv.adjustm.        (S3) TABS, 41/21.2/0639, 0640  Side effects: Hypoglycaem., skin/sens.reacts., headache, GI dis-
   Type 2 diab.mellit.in combinat.with GLP-1 recept. agonist:   714427-001: 500 mg, 100, R40,53  turbs., metal.taste, dizzin., weakn., bld.dyscras., paraesthes.
   When add.Tresiba to GLP-1 recept. agonist.init.recomm.dly start.  714426-001: 850 mg, 60, R44,46  Special precautions: Incr.assoc.of CV mortal. compar.to treatm.
   dos is 10 U once dly follow.by indiv.adjustm; When add GLP-1 re-  Dosage: Admin.in div.dos.with meals.  with diet alone/diet & insul., hepat.& ren.impairm., recurr.infects.,
   cept. agon.to Tresiba a 20%Tresiba dos.reduct. recomm. to minim.  Adults: Init.500 mg 3x.dly with/aft.food. Aft.10-15 days incr.to   trauma, surg.
   hypoglycaem.risk. Subseq, dosage should be adjust.  850-1000 mg 2x/day. Incr.to max. 3 g/dly.if contr.incompl. Reduc.  Drug interactions: Sulphonamid., salicylat., phenylbutazone, ß-
   Type 1 diab.mellit: Admin.once dly.with mealt. insul. & subseq.  dos.once contr. achiev.  adrenocept.block.agents, MAOI, ketoconazole & miconazole, clofi-
   adjust. dos. indiv.          Contraindications: Diabet.ketoacidos./-pre-coma or hist.thereof,   brate/halofenate/ cyclophosphamide/chloramphenicol/dicoumarol
   Tfd.from other insul.med.prod: Indiv.dos., see manufact. lit.  imp.ren.funct., pancreatit., chron. liv.dis., hist.of/states assoc.with   & cimetidine may potent.act., thiazide diuret., corticoster., oestrog.
   Contraindications: Pregn., do not admin.IV/IM/in insul.infus.pumps.  lactat. acidos., CF, recent MI, hypox.assoc.condits., hepat. insuff.,   & adrenaline may dimin.act.
   Side effects: Very comm: Hypoglycaem. Comm: Inj.site reacts.   ac.alcoh.intoxicat., alcoh., safety in pregn.& lactat.not est., safety   AMARYL, Sanofi-Aventis [P/S]
   Uncomm: Periph.oed., lipodystr. Rare: Hypersens., urticar.  & effic.in childr. not est.  Glimepiride.
   Warnings and special precautions: Hypoglycaem., decr.sensitiv.  Side effects: Lact.acidos., megaloblast.anaem., decr. Vit.B 12 & fo-  Indications: Adjunct.in non insul.depend.diabet. mellit.not contr.
   to usual hypoglycaem. warn.sympts.in pts.with improv.bld.gluc.con-  lic acid absorpt., metall. taste, GI disturbs., sev.cholestat.hepatit.,   by diet & exerc.alone, combin.ther. with metform.when.contr. with
   trol/ long-stand.diab., incr.insul.requirem.with infects.& fev., poss.dos.  ketoacidos., ketonur., hypersens., hypoglycaem.  max.dly.dos.of either glimepiride/metformin not adeq.
   changes with concom.kidn./liv/ adren./ pituit & thyroid dis., recovery   Warnings and special precautions: Discont. & hospitalis. im-  (S3) TABS. 30/21.2/0060, 0061, 0063.
   from hypoglycaem. poss.delay., match insul.dos (esp.in basal-bolus   med.if metabol.acidos.suspect., reg. ren.funct.monit.esp.creatin.  831557-001: 1 mg, 30, R129,95
   regim.) with food intake & physic. activit. in childr.to min.risk of hy-  lev., diabet./ elderly with imp.ren.funct., condits.where ren. funct.   831565-004: 2 mg, 30, R246,90
   poglycaem., should not be used for sev.hyperglycaem.treatm., med.   may become imp., incr.cardiovasc.mortal. compar. to diet alone/  831573-007: 4 mg, 30, R456,48
   supervis.if transf.to other insul.types/brands/ manufact., CHF report.  diet + insul.ther., discont. 48 hrs.bef.elect.surg.with gen.anaesth.&   Dosage: Swallow.whole. Usual.longt.ther. Dos. determ.by bld.gluc.
   with concom. thiazolidinediones esp.if CHF risk fact.pres., observ. pt   re-instit. 48 hrs. afterw., contin.diet with reg. distribut. of carbohydr.  lev. at dos.low.to achiev.desir. metabol.contr. Do not take subseq.larg.
   for S&S of CHS/weight gain/oed.with concom. thiazolidinediones ,   intake dur.day, energy-restrict. diet in overweight pts., not recomm.  dos.if dos. forgot. Init: 1 mg once dly. If necess. may be grad. incr.
   discont.concom. thiazolidinediones if any sign of card.funct. deterio-  in type 1 diab.mellit.in childr., discont.ther.prior intravasc. admin.  at interv.of 1-2 wks.by 1 mg-2 mg-3 mg-4 mg-6 mg. Max.dos.8 mg/
                                of iodinat.contrast mater. reinstit. unt.48 hr.afterw.once ren.funct.
   rat. occurs, revers.ophthalmolog. refract. disord./ worsen.of diabet.  day. Addit.metform.treatm. init.with low dos.then titrat.up depend.
   retinopathy & ac.painf. periph. neuropathy assoc.with intensificat./  eval., not advis. in condits.caus.dehydrat./ser.infect./ trauma/ low   on desir. metabol. contr.lev.up to max.dly dos. Init.& monit. by med.
                                cal. intake, annual vit.B12 estimat., monit. bld.gluc.dur,concom.
   rapid gluc. control improvem., rotate inj.sites to reduc. lipodystrophy   pract. Usual.dly.dos: 1-4 mg taken immed. bef.a subst.breakf./1st
   risk, do not add to infus.fluids/ mix.with other meds., elderly, ren./  sulphonylurea ther., poss. hypoglycaem.with combin.ther., stabilis.  main.meal usual.at same time dly. Do not skip meals aft.tabs.ad-
   hepat. impairm., no clin.exper.in breast-feed.  pts in hosp.if concom.insulin admin., avoid alcoh.& alcoh. contain.  min. With improv.diab.contr.dos.adjustm.poss.necess. Dos. correct.
   Interactions: CHF report.with thiazolidinediones, oral antidiabet.  meds., more freq.bld.gluc.monit. esp. init.with concom.glucocortic./  in case of incr.suscept.to hypo-/hyperglycaem. When switch.from
   meds./GLP-1 recept.agon./MAOI/ beta-block./ACE inhibit./sa-  beta-2-agon./ diurets.  other oral antidiab.init.treatm.as above.
   licylates/anabol.ster & sulphonamides may reduc.insul.requirem.,   Interactions: Alcoh.intoxicat.incr.lact.acidos. risk, glucocortic./beta-  Contraindications: Sulphonylurea or other sulphonamide hyper-
   OC’s/ thiazides/glucocorticoids/thyroid horm./ sympathomimet/   2-agon.& diuret.have intrins. hyperglycaem.activ., ACE inhibit. decr.  sens., safety in pregn.& lactat. not est., imp.liv.funct., childr., insul.-
                                bld. gluc.lev., reduc.ren.clear.with cimetidine, activ.of warfar. dimin.,
   growth horm & danazol may incr. insul. requirem., beta-block.poss.  depend.(type 1) diab. mellit., rare heredit.galact. intol.probl., Lapp
   mask hypoglycaem. sympts.& reduc.body’s response, octreotide   hypoglycaem.with sulphonylur., Vit.B 12 mal-absorpt.with longt.use.  lact.defic., gluc.-galact. malabsorpt.
   & lanreotide may incr./decr.insul. requirem., alcoh.intensif./reduc.  ACCORD PIOGLITAZONE, Accord [P/S]  Side effects: Hypoglycaem.and poss.adrenerg. counter-regulat.
   insul.hypoglycaem. eff.      Pioglitazone                  signs, tempor.vis.impairm.esp.at start of treatm., GI disturbs., hep-
                                Indications: Adjunct to diet & exercise in Type 2 diab. either as   atit., elev.liv. enzym. lev.&/cholestas., jaund., liv.fail., bld. dyscras.,
                                monother./in combinat.with metformin, a sulphonylurea or insulin   skin rash., urticar./itch.poss.devel.into ser. react./shock, allerg.vas-
   19.1.2   Oral agents         when diet &/exerc.& sngl.agent result inadeq.glycaem. control.  culit., light hypersens. of skin, hypo-/hyperglycaem.reacts.esp.when
                                (S3) TABS, 43/21.2/0140, 0141, 0142
                                                              init./ alt.ther./irreg.admin.
   GLUCOPHAGE XR (MDR Listing)  718148-001: 15 mg, 30, R92,36  Special precautions: Incr.card.vasc.mortality report.with admin.
                                718150-001: 30 mg, 30, R155,08  of oral hypoglycaem.as compar. to diet alone/ diet plus insul., pt.to
   ACCORD GLIMEPIRIDE, Accord [P/S]  718151-001: 45 mg, 30, R246,99  be inform.of benef. vs.risk of ther./alt.treatm., temp.change to insul.
   Glimepiride.                 Dosage: Indiv. Take once dly.without regard to meals.  poss.necess.in stress situat., reg.measurem. of bld.& urine gluc.
   Indications: Type 2 diab.mellit.not control.by diet. & exerc.alone.  Monother: Init.15 or 30 mg once dly.incr.if necess. in increm.to   lev.& glycat.Hb proport., ren. insuffic., phys.to be advis.of urticar./
   (S3) TABS. 41/21.2/0656, 0657, 0658  max.45 mg once dly.   hypoglycaem. episod., lifestyle chang., incr.hypoglycaem.risk at ther.
   716714-001: 1 mg, 30, R52,77  Combinat.ther: Sulphonylur: Init.15 or 30 mg once dly.in com-  init., insul.treatm.of choice for NIDDM with ren.& hepat.dysfunct.,
   716715-001: 2 mg, 30, R104,44  binat. with curr.dos.of sulphonylur. If hypoglycaem. report.decr.  fact.favour.hypoglycaem., uncompens. disords.of endocr.syst.affect.
   716716-001: 4 mg, 30, R164,93  sulphonylurea dos.          carbohydr. metabol., G6PD defic.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page324.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page320.html">320</a>&nbsp;&nbsp;&nbsp;<a href="page321.html">321</a>&nbsp;&nbsp;&nbsp;<a href="page322.html">322</a>&nbsp;&nbsp;&nbsp;<a href="page323.html">323</a>&nbsp;&nbsp;&nbsp;<a href="page324.html">324</a>&nbsp;&nbsp;&nbsp;<a href="page325.html">325</a>&nbsp;&nbsp;&nbsp;<a href="page326.html">326</a>&nbsp;&nbsp;&nbsp;<a href="page327.html">327</a>&nbsp;&nbsp;&nbsp;<a href="page328.html">328</a>&nbsp;&nbsp;&nbsp;<a href="page329.html">329</a>&nbsp;&nbsp;&nbsp;<a href="page330.html">330</a>
             </td>
             <td width="35%"><a href="page326.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page326.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
